Home › Funds › Laurion Capital Management LP › PYXS
Laurion Capital Management LP position in PYXS
PYXIS ONCOLOGY INC · Health Care
Laurion Capital Management LP reported holding 4,989,888 shares of PYXS (PYXIS ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$11.6M, representing 0.63% of its reported portfolio and ranking #38 among its reported holdings. Laurion Capital Management LP has disclosed PYXS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Laurion Capital Management LP's PYXS position evolved
Laurion Capital Management LP first disclosed a stake in PYXS in Q3 2023 at 3,170,803 shares (US$6.3M). The position peaked in Q1 2024 at 3,861,179 shares, worth US$16.4M. Across 13 filings, Laurion Capital Management LP increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 4,989,888 shares valued at US$11.6M — an increase of 89,000 shares quarter over quarter.. Notable position changes include a 32% increase in Q4 2025 (shares rose 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.17M | $6.31M | New |
| Q4 2023 | 3.17M | $5.71M | Hold |
| Q1 2024 | 3.86M | $16.45M | Add |
| Q2 2024 | 3.86M | $12.78M | Hold |
| Q3 2024 | 3.63M | $13.31M | Reduce |
| Q4 2024 | 3.63M | $5.66M | Hold |
| Q1 2025 | 3.63M | $3.55M | Hold |
| Q2 2025 | 3.63M | $3.99M | Hold |
| Q3 2025 | 3.63M | $8.05M | Hold |
| Q4 2025 | 4.80M | $5.52M | Add |
| Q1 2026 | 5.00M | $7.30M | Add |
| Q2 2026 | 4.90M | $14.75M | Reduce |
| Q3 2026 | 4.99M | $11.63M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PYXS and 13F data
PYXS (PYXIS ONCOLOGY INC) is a Health Care company. 31 other funds we track also report a position in PYXS — the largest reported positions include GordonMD Global Investments LP (US$30.2M), PFIZER INC (US$20.1M), Palo Alto Investors LP (US$2.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PYXS
- GordonMD Global Investments LP 10.02M sh · $30.17M · Q2 2026
- PFIZER INC 7.03M sh · $20.11M · Q3 2026
- Palo Alto Investors LP 864.28K sh · $2.60M · Q2 2026
- Blue Owl Capital Holdings LP 1.00M sh · $2.33M · Q3 2026
- Atle Fund Management AB 663.77K sh · $1.55M · Q3 2026
- Decheng Capital LLC 326.81K sh · $983.70K · Q2 2026
- Monashee Investment Management LLC 229.31K sh · $534.29K · Q3 2026
More on Laurion Capital Management LP
FAQ
How long has Laurion Capital Management LP held PYXS?
Laurion Capital Management LP has disclosed PYXS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Laurion Capital Management LP's current position in PYXS?
As of Q3 2026, Laurion Capital Management LP holds 4.99M shares of PYXS (PYXIS ONCOLOGY INC), valued at $11.63M, representing 0.63% of its reported portfolio and ranking #38.
Has Laurion Capital Management LP been buying or selling PYXS?
In the latest 13F filing (Q3 2026), Laurion Capital Management LP increased its position in PYXS. The position peaked in Q1 2024 at 3.86M shares.
Which other funds hold PYXS?
Other major institutional holders of PYXS include GordonMD Global Investments LP, PFIZER INC, Palo Alto Investors LP, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.